White bile in patients with malignant biliary obstruction is an independent factor of poor survival

Abstract

Background and study aims White bile is defined as a colorless fluid occasionally found in the biliary tract of patients with bile duct obstruction. Its significance is not clearly established. Our objective was to analyze the prognostic value of white bile in a series of patients with biliary obstruction due to biliary or pancreatic cancer.

Patients and methods The study was conducted on a series of consecutive patients with malignant obstructive jaundice. They all underwent endoscopic retrograde cholangiopancreatography with collection of bile and biliary stent insertion. White bile was defined as bile duct fluid with bilirubin level < 20 µmol/L. Univariate and multivariate analyses were performed to identify variables associated with overall survival (OS).

Results Seventy-three patients were included (32 pancreatic cancers, 41 bile duct cancers). Thirty-nine (53.4 %) had white bile. The mean bile duct bilirubin level in this group was 4.2 ± 5.9 µmol/L vs 991 ± 1039 µmol/L in patients with colored bile (P < 0.0001). In the group of 54 patients not eligible for surgery, the multivariate analysis demonstrated an association between the presence of white bile and reduced OS (HR 2.3, 95 %CI 1.1–4.7; P = 0.02). Other factors independently associated with OS were metastatic extension (HR 2.8, 95 %CI 1.4–5.7) and serum total bilirubin (HR 1.003, 95 %CI 1.001–1.006). There was a significant inverse correlation between serum and bile duct bilirubin levels (r = –0.43, P = 0.0001).

Conclusion White bile in patients with inoperable malignant biliary obstruction is an independent factor of poor survival.

Publikationsverlauf

Eingereicht: 24. April 2020

Angenommen: 21. September 2020

Artikel online veröffentlicht:
03. Februar 2021

• References

• 1 Judd ES, Lyons JH. White bile in the common bile duct. Ann Surg 1923; 77: 281-292
• 2 Edington GH, McCallum G. The occurrence of “White Bile” in gallstone obstruction: note of a case with histological note. Glasgow Med J 1930; 114: 257-264
• 3 Ahuja V, Garg PK, Kumar D. et al. Presence of white bile associated with lower survival in malignant biliary obstruction. Gastrointest Endosc 2002; 55: 186-191
• 4 Neilan RE, Groce JR, Jalil S. et al. White bile (with video). Gastrointest Endosc 2007; 66: 180-181
• 5 Gremida A, Rustagi T. White bile in malignant biliary obstruction: a poor prognostic marker. Clin Endosc 2018; 51: 109-110
• 6 Ahuja V, Garg PK, Tandon RK. Of “horned toads”and “horned frogs”. Gastrointest Endosc 2002; 56: 783
• 7 Yarze JC. White bile: a “clear” misnomer. Gastrointest Endosc 2002; 56: 782-783
• 8 Griffiths DB, Haber MH, Rees KR. et al. Analysis of white bile in a case of cholangiocarcinoma of the hepatic ducts. J Pathol Bacteriol 1963; 85: 389-393
• 9 Bouchier AD, Cooperband SR. The characteristics of “white bile” . Gastroenterology 1965; 49: 354-359
• 10 Elmslie RG, Thorpe MEC, Colman JVL. et al. Clinical significance of white bile in the biliary tree. Gut 1969; 10: 530-533
• 11 Rous P, McMaster PD. Physiological causes for the varied character of stasis bile. J Exp Med 1921; 34: 75-95
• 12 Flint ER. Obstructions of the common bile duct. Br Med J 1937; 2: 253-256
• 13 Imbert-Bismut F, Messous D, Thibault V. et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors. Clin Chem Lab Med 2004; 42: 323-333
• 14 Jung JT, Kim HG, Han J. et al. [Clinical significance of white bile (bilirubin-free bile) in malignant bile duct obstruction]. Korean J Gastroenterol 2008; 52: 91-96 Korean
• 15 Hashmonai M, Kam I, Schramek A. The etiology of “white bile” in the biliary tree. J Surg Res 1984; 37: 479-486